Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Orthofix International N.V. (NASDAQ: OFIX) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Orthofix International N.V. (NASDAQ: OFIX) concerning whether a series of statements by Orthofix International N.V. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On December 16, 2016, SeekingAlpha.com published a report revealing how the "FDA is actively moving to 'down classify' BGS from Class III to Class II, allowing cheap competition to flood in, stealing revenues and crushing margins." The report goes on to state that "as of October 1st, 2016 the FDA just transferred the BGS down classification process to the specific department responsible for handling the down classification (the department of Orthopedics)."

On this news, NASDAQ: OFIX has fallen over 8% during intraday trading on December 16, 2016.

Based in Willemstad, Curaçao, and founded in 1987 Orthofix International N.V. provides reconstructive and regenerative orthopedic and spine solutions to physicians worldwide.

If you purchased shares of Orthofix International N.V. (NASDAQ: OFIX) on or before December 16, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185